<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Regulation of haemopoiesis in the marrow of patients with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) was evaluated by assaying (1) the production of haemopoietic regulators acting upon multipotent and committed progenitors by <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> marrow cells, and (2) the responsiveness of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> marrow progenitors to stimulation with granulocyte colony-stimulating factor (G-CSF) </plain></SENT>
<SENT sid="1" pm="."><plain>The levels of multipotent progenitor cell colony-stimulating activity (CFU-GEMMCSA) in 7 d bone marrow-conditioned medium (BMCM) from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients were markedly reduced as compared to controls </plain></SENT>
<SENT sid="2" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> BMCM also exhibited reduced levels of burst-promoting activity (BPA) for primitive erythroid (BFU-E) progenitors </plain></SENT>
<SENT sid="3" pm="."><plain>Both CFU-GEMMCSA and BPA detected in BMCM were completely neutralized by antibodies directed against interleukin-3 </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> BMCM exhibited markedly reduced levels of murine-active CSA </plain></SENT>
<SENT sid="5" pm="."><plain>This activity was partially neutralized by anti-CSF-1 antibodies </plain></SENT>
<SENT sid="6" pm="."><plain>Levels of regulators in BMCM of refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> (RA), sideroblastic <z:hpo ids='HP_0001903'>anaemia</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>RA with excess blasts, and <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocyte <z:mpath ids='MPATH_336'>leukaemia</z:mpath> were virtually the same </plain></SENT>
<SENT sid="8" pm="."><plain>CFU-GEMM and BFU-E growth in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> marrow (n = 9) was markedly reduced </plain></SENT>
<SENT sid="9" pm="."><plain>A 5-fold saturating dose of G-CSF induced an approximately 2-fold increase in CFU-GEMM in four of eight <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and a 1.5-fold increase of BFU-E in five of nine <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, but not in control (n = 5) marrow cell cultures </plain></SENT>
<SENT sid="10" pm="."><plain>Impaired haemopoiesis in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> marrow may be related to abnormalities both in regulator production by marrow accessory cells and in regulator responsiveness of multipotent and committed progenitors </plain></SENT>
</text></document>